Apyx Medical CorporationAPYXNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-9.5%
5Y CAGR-3.0%
Year-over-Year Change
Research and development spending
3Y CAGR
-9.5%/yr
vs +16.5%/yr prior
5Y CAGR
-3.0%/yr
Recent deceleration
Acceleration
-25.9pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.37M | -33.6% |
| 2024 | $5.08M | +4.9% |
| 2023 | $4.84M | +6.6% |
| 2022 | $4.54M | +5.2% |
| 2021 | $4.32M | +10.2% |
| 2020 | $3.92M | +5.1% |
| 2019 | $3.73M | +51.1% |
| 2018 | $2.47M | +0.6% |
| 2017 | $2.46M | -6.2% |
| 2016 | $2.62M | - |